Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
TMO A A DGX Technology Heavy Metals Software 
United States GSPC USD ...  |  Create Portfolios


Processing
Collecting data for PRXL

PAREXEL quote and profile

 
 Companies |  Insiders  | Dashboard  
     
46.37
  
STOCK
0.00  No Change   0.00%  
Year To Date
23.7546.83
Last 1 Month(s)
39.9346.83
May 22 2013 

Diversification Suggestion

Use PAREXEL to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Analyze PAREXEL International Trend or Check current 30 days PAREXEL correlation with market (S&P 500)
1 Month Beta 0.31  
Highest Price:  
Lowest Price:  
46.83  
39.93  
May 16 2013 
April 22 2013 
As returns on market increase, PAREXEL returns are expected to increase less than the market. However during bear market, the loss on holding PAREXEL will be expected to be smaller as well.
PAREXEL International Corporation Small BetaPAREXEL International Beta Legend
PRXL United States Nasdaq
PAREXEL International Corporation
Healthcare
Medical Laboratories and Research
Benchmark S&P 500
http://www.parexel.com
Contact Number: 781. 487. 9900
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation2.43 B
Shares Outstanding58.14 M
Number of Shares Shorted3.42 M
Revenue1.57 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States SP 500   0.17 % Macroaxis: 0.17 Moved Up  
 
 United States NYSE   0.11 % Macroaxis: 0.11 Moved Up  
 
 United States Russel   0.08 % Macroaxis: 0.08 Moved Up  
 
 thisGreen PRXL PRXL agains markets  0.00 % No Change  
Compare to Competition Get Alpha   Get Advice

PAREXEL Leadership

Christopher Lindop Director, Chairman of Audit and Fin. Committee, Member of Nominating and Corporate Governance Committee, CFO of Haemonetics Corporate and VP of Bus. Devel. - Haemonetics Corporate
Josef Rickenbach Founder, Chairman and CEO, MBA
Douglas Batt Senior Vice President General Counsel, Secretary
Joseph Avellone Senior Vice President - Clinical Research Services

PAREXEL Price and Market Media

The median price of PAREXEL for the period between Mon, Apr 22, 2013 and Wed, May 22, 2013 is 44.49 with a coefficient of variation of 5.68. The daily time series for the period is distributed with a sample standard deviation of 2.48, arithmetic mean of 43.72, and mean deviation of 2.1. The Stock received substential amount of media coverage during this period.
PAREXEL         SP 500
Price Growth (%)
 
1
PAREXEL INTERNATIONAL CORPORATION PAREXEL Honored with 2013 ...04/25/2013Macroaxis: News
2
Parexel International Earnings Everything You Must Know Now05/01/2013Macroaxis: News
3
Charles River Misses Estimates in 1Q05/03/2013Macroaxis: News
4
PAREXEL International Stock Rating Upgraded by Zacks05/08/2013Macroaxis: News
5
PAREXEL International Announces Acquisition of HERON Group L...05/10/2013Macroaxis: News

PAREXEL Summary

PAREXEL International Corporation [PRXL] is traded on NASDAQ in USA. It is located in Waltham, MA and employs 12,695 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.53 B. PAREXEL International Corporation conducts business under Healthcare sector and is part of Medical Laboratories and Research industry. This company has 58.14 M outstanding shares of which 3.42 M shares are at this time shorted by private and institutional investors with about 6.1 trading days to cover.
PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, medical communications, consulting, commercialization, and advanced technology solutions and services to the pharmaceutical, biotechnology, and medical device industries worldwide. more
Past Market
Over 30
Days
23
Out Of
100
 
Chance of
Less
Than
16 %
 
Follow PAREXEL with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add PAREXEL to your reader
 

PAREXEL Research Report

PAREXEL vs. Thermo

Correlation analysis and fundamentals comparison between PAREXEL International and Thermo Fisher Scientific

PAREXEL Executives

James Winschel CFO, Principal Accounting Officer, Sr. VP and Treasurer, MBA
Mark MD Pres and COO
Mark Goldberg COO

PAREXEL Directors

A Callow Independent Director
Eduard Holdener Independent Director
Richard Love Independent Director
Patrick Fortune Independent Director
Ellen Zane Independent Director

PAREXEL Management

Ulf Schneider Chief Admin. Officer and Sr. VP

PAREXEL Fundamentals

Operating Margin vs Debt to Equity
Revenue vs Price to Sales
Operating Margin vs Number of Shares Shorted
Price to Earning vs Price to Sales

PAREXEL vs Competition

PAREXEL vs. Thermo Fisher Scientific Inc
PAREXEL vs. Agilent Technologies Inc
PAREXEL vs. Quest Diagnostics Inc
PAREXEL vs. Laboratory Corp of America Holdings
PAREXEL vs. MettlerToledo International Inc
PAREXEL vs. Covance Inc
PAREXEL vs. PerkinElmer Inc
PAREXEL vs. Alere Inc

PAREXEL May 22 2013 Opportunity Range

Downside Deviation0.9378
Information Ratio0.2462
Maximum Drawdown5.79
Value At Risk(0.66)
Potential Upside3.13

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium